Some biotech investors have been thriving by focusing on mergers, short selling and Covid-19 stocks
There may be more of these kinds of deals in 2022, investors say, as cash-heavy pharmaceutical companies look to buy growing biotech companies. Smaller biotech companies may be more inclined to sell after suffering in 2021, the investors say.Biotech short sellers profited in 2021, as well.
Some traders lost money because they hedged their biotech portfolios with bets against the S&P 500, which is up over 20% on the year. Of course, Covid-19 vaccine stocks were the stars of 2021, though many have fallen sharply from recent highs.started the year over $100, approached $500 in the summer, and now trades around $275, still up sharply on the year.
After Merck’s Covid-19 vaccine candidates failed, the drugmaker partnered with rival Johnson & Johnson. WSJ reporter Jared Hopkins takes us behind the scenes, as the first Merck-made shots are released for distribution. Photo: Hannah Yoon/WSJ “Anything that’s Covid-related has done well, or at least held up,” says Brad Loncar at Loncar Investments, which created two biotech exchange-traded funds.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 Vaccine Education and Equity Project’s Statement on the Anniversary of the Authorization of the First COVID-19 Vaccines - COVID-19 Vaccine Education and Equity ProjectCOVID-19 Vaccine Education and Equity Project’s Statement on the Anniversary of the Authorization of the First COVID-19 Vaccines To mark the milestone one-year anniversary of the authorization of the first COVID-19 vaccines in the U.S., the conveners of the COVID-19 Vaccine Education and Equity Project shared the following statements...
Read more »
Norway to tighten COVID-19 restrictions, PM saysNorway will further tighten restrictions this week in order to limit the spread of the coronavirus, Prime Minister Jonas Gahr Stoere told news agency NTB on Monday.
Read more »
Why U.S. Job Gains Are So Hard to Count During Covid-19The government is getting less data from employers, and economists are having a hard time understanding how the pandemic affects consumer and business behavior.
Read more »
Another grim Covid-19 milestone: At least 800,000 Americans have diedBREAKING: More than 800,000 Americans have now died from Covid-19, a total larger than the population of Boston, Washington, D.C. or Seattle, according to a rolling tally by NBCNews
Read more »
U.S. Approaches 800,000 Covid-19 Deaths — These 5 States Have The Highest Fatality RatesI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Read more »
Masks come off, rallies begin as India's COVID-19 patient load fallsIndia reported its lowest tally of active COVID-19 cases in 18 months on Monday, but a sharp drop in the use of protective face masks is causing concern after a rise in the number of infections with the Omicron variant.
Read more »